HINDU WORLD - ENCYCLOPEDIC SURVEY OF HINDUISM, I-II - WALKER,B

被引：0
作者：
EMBREE, AT [1 ]
机构：
[1] DUKE UNIV,DURHAM,NC
来源：
JOURNAL OF ASIAN HISTORY | 1971年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
K [历史、地理];
学科分类号：
06 ;
摘要：
引用
收藏
页码：58 / 60
页数：3
相关论文
共 50 条
  • [41] Mulberry B Harbor Multibeam Survey High-Resolution Coverage of World War II Artifacts in French Port
    Howlett, Chris
    Mallace, Duncan
    SEA TECHNOLOGY, 2013, 54 (06) : 10 - +
  • [42] A Randomized Control Trial of Dexketoprofen/Vitamin B (Thiamine, Pyridoxine and Cyanocobalamin) Fixed-Dose Combination in Post-Traumatic Grade I-II Cervical Sprains
    Delgado-Garcia, Pamela
    Alcocer-Herrera, Juan Bautista
    Urenda-Quezada, Adelfia
    Alonso-Martinez, Maria Dolores
    Bautista-Mendoza, Maria Arcelia
    Romero-Antonio, Yulia
    Mora-Villalobos, Julio C.
    Sander-Padilla, Jose G.
    Rios-Brito, Kevin F.
    Rodriguez-Vazquez, Ileana C.
    Gonzalez-Canudas, Jorge
    CLINICAL DRUG INVESTIGATION, 2024, 44 (06) : 413 - 424
  • [43] Seroprevalence of syphilis, hepatitis B, hepatitis C, toxoplasmosis, Chagas' disease and HTLV I-II among HIV infected patients assisted in a Buenos Aires city hospital
    Scapellato, PG
    Bottaro, E
    Brieschke, MTR
    Dato, A
    Rudoy, S
    Vidal, GI
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1215 - 1215
  • [44] Immunoreactivity for CD10 but not for bcl-6 plays a prognostic role in stage I-II diffuse large B-cell lymphomas of the stomach (PGL)
    Ponzoni, M
    Ferreri, AJM
    Pruneri, G
    Pozzi, B
    Dell'Oro, S
    Pigni, A
    Pinotti, G
    Freschi, M
    Villa, E
    Viale, G
    Capella, C
    MODERN PATHOLOGY, 2002, 15 (01) : 259A - 259A
  • [45] Phase I-II trial of VACOP-B plus filgrastim (G-CSF) support for HIV-related non-Hodgkins lymphoma (NHL).
    Crump, M
    Shepherd, FA
    Routy, JP
    Walker, I
    St Louis, J
    Brandwein, J
    Taylor, M
    Meyer, RM
    Sawka, CA
    BLOOD, 2000, 96 (11) : 138A - 138A
  • [46] Immunoreactivity for CD10 but not for bcl-6 plays a prognostic role in stage I-II diffuse large B-cell lymphomas of the stomach (PGL)
    Ponzoni, M
    Ferreri, AJM
    Pruneri, G
    Pozzi, B
    Dell'Oro, S
    Pigni, A
    Pinotti, G
    Freschi, M
    Villa, E
    Viale, G
    Capella, C
    LABORATORY INVESTIGATION, 2002, 82 (01) : 259A - 259A
  • [47] 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer
    Pierce, LJ
    Moughan, J
    White, J
    Winchester, DP
    Owen, J
    Wilson, JF
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (01): : 183 - 192
  • [48] Feasibility survey (phase I-II) of a four drugs combination (5-fluorouracil, folinic acid, carboplatin and irinotecan) delivered using a chronomodulated infusion in the treatment of advanced colorectal cancer
    Focan, C
    Kreutz, F
    Graas, MP
    Longrée, L
    Moeneclaey, N
    David, A
    Focan-Henrard, D
    PATHOLOGIE BIOLOGIE, 2005, 53 (05): : 277 - 280
  • [49] Combination chemotherapy with capecitabine (C), irinotecan (I), oxaliplatin (O), and bevacizumab (B; XELOXIRIA) as first-line treatment of metastatic colorectal cancer (MCRC): Preliminary results of a phase I-II trial.
    Bazarbashi, S.
    Aljubran, A. H.
    Soudy, H.
    Darwish, A.
    Eltigani, A.
    Nabil-Ahmed, M.
    Edesa, W.
    Almubarak, M.
    Abu Sabaa, A.
    Shoukri, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] N-terminal protype-B natriuretic peptide and Doppler diastolic variables are incremental for risk stratification of patients with NYHA class I-II systolic heart failure
    Dini, F. L.
    Fontanive, P.
    Ciuti, M.
    Chella, P.
    De Tommasi, S. M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 879 - 879
12345